Alina R. Elfimova

Alina R. Elfimova

Auto-generated profile, based on publicly available information

Alina R. Elfimova

Endocrinology Research Centre

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2022 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
MSMarina Shestakova
Marina Shestakova
OVO. K. Vikulova
O. K. Vikulova
AEA. R. Elfimova
A. R. Elfimova
MIM. A. Isakov
M. A. Isakov
IDI. I. Dedov
I. I. Dedov
BACKGROUND: The coronavirus pandemic has had an extremely negative impact on the patients with diabetes mellitus (DM both in terms of a more severe course of COVID -19 and an increased risk of death.AIM: Analysis of risk factors for death due to COVID -19 in patients with DM type 1 and type 2 (DM1 and DM2).MATERIALS AND METHODS: Retrospective analysis of the database of the national diabetes register (NDR), which included DM patients with COVID-19 and reported virus infection outcome (recovery/or death) in 15 712 DM1 and 322 279 DM2 patients during a 2-year follow-up period (01/02/2020 to 03/04/2022) (discharge date)).RESULTS: Case fatality rate in patients with DM, who underwent COVID -19 was 17.1% (DM1–8.8%; DM2–17.5%). As a result of multivariate regression analysis of seven significant factors in DM1 and thirteen in DM2 (evaluated by univariate anlisys), a number of the most important predictors of risk for fatal outcome were identified: in DM1 these were age ≥65 years (OR =4.01, 95% CI: 1.42–11.36), presence of arterial hypertension (AH) (OR =2.72, 95% CI: 1.03 -7.16) and diabetic foot syndrome (DFS) (OR = 7.22, 95% CI: 1.98–26.29); for T2DM: age ≥ 65 years (OR =2.53, 95% CI: 1.96–3.27), male (OR =1.51, 95% CI: 1.23–1.84), duration DM ≥10 years (OR =2.01, 95% CI: 1.61–2.51), BMI ≥ 30 kg/m2 (OR =1.26, 95% CI: 1.02–1.55), ASCVD/CKD (OR =1.49, 95% CI: 1.01–2.04), history of diabetic coma (OR =12.97, 95% CI: 1.89–88.99) and presence of disability ( OR =1.40, 95% CI: 1.14–1.73). In T2DM, the type of antidiabetic therapy (ADT) prior to COVID -19 (last visit before the development of infection) had a significant impact: Insulin therapy (OR = 1.64, 95% CI: 1.30–2.07), sulfonylureas (SU) (OR =1.51, 95% CI: 1.23–1.84)); dipeptidyl peptidase-4 inhibitor (iDPP-4) therapy (OR =0.57, 95% CI: 0.39–0.83) and sodium-glucose cotransporter-2 inhibitor (iSGLT2) therapy (OR =0.64, 95% CI: 0.46–0.88). Vaccination was the most important protective factor in both types of DM: DM1 OR =0.19, 95% CI: 0.06–0.59; SD2 OR =0.20, 95% CI: 0.16–0.26.CONCLUSION: The common risk factor for fatal outcome in both DM1 and DM2 was age ≥65 years; in DM1 — history of hypertension and DFS, in DM2 — male sex, diabetes duration ≥10 years, BMI ≥30 kg/m2, history of ASCVD/CKD and diabetic coma, disability. In T2DM, significant differences in risk were observed depending on the type of ADT: insulin and SU therapy were factors that increased the risk of death, whereas therapy with iDPP-4 and iSGLT2 reduced the risk of death. Vaccination reduced the risk of death in DM1 and DM2 by 5.2 and 5-fold, respectively.

9 March 2023 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
EBEkaterina E. Bibik
Ekaterina E. Bibik
EDEkaterina A. Dobreva
Ekaterina A. Dobreva
AEAlina R. Elfimova
Alina R. Elfimova
APAnastasiia Pershina-Miliutina
Anastasiia Pershina-Miliutina
AEAnna Eremkina
Anna Eremkina
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
Background: Components of metabolic syndrome can be observed in patients with primary hyperparathyroidism (PHPT). The link between these disorders remains unclear due to the lack of relevant experimental models and the heterogeneity of examined groups. The effect of surgery on metabolic abnormalities is also controversial. We conducted a comprehensive assessment of metabolic parameters in young patients with PHPT. Methods: One-center prospective comparative study was carried out. The participants underwent a complex biochemical and hormonal examination, a hyperinsulinemic euglycemic and hyperglycemic clamps, a bioelectrical impedance analysis of the body composition before and 13 months after parathyroidectomy compared to sex-, age- and body mass index matched healthy volunteers. Results: 45.8% of patients (n = 24) had excessive visceral fat. Insulin resistance was detected in 54.2% of cases. PHPT patients had higher serum triglycerides, lower M-value and higher C-peptide and insulin levels in both phases of insulin secretion compared to the control group (p < 0.05 for all parameters). There were tendencies to decreased fasting glucose (p = 0.031), uric acid (p = 0.044) and insulin levels of the second secretion phase (p = 0.039) after surgery, but no statistically significant changes of lipid profile and M-value as well as body composition were revealed. We obtained negative correlations between percent body fat and osteocalcin and magnesium levels in patients before surgery. Conclusion: PHPT is associated with insulin resistance that is the main risk factor of serious metabolic disorders. Surgery may potentially improve carbohydrate and purine metabolism.

22 June 2022 in Consilium Medicum
Verified
Journal Article
Open access
PDF file
OVOlga K. Vikulova
Olga K. Vikulova
AEAlina R. Elfimova
Alina R. Elfimova
AZAnna Zheleznyakova
Anna Zheleznyakova
MIMikhail А. Isakov
Mikhail А. Isakov
MSMinara S. Shamkhalova
Minara S. Shamkhalova
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
Background. Chronic kidney disease (CKD) is a socially significant pathology associated with an increased risk of mortality and progression to terminal stages, requiring expensive treatment with renal replacement therapy, which determines the priority of preventive strategies, especially in patients with diabetes mellitus (DM), who are at high risk of Kidney's injury. Aim. To analyze the predictors of a decrease in glomerular filtration rate (GFR) less than 60 ml/min/1.73 m2 and develop an applied CKD prediction calculator in patients with type 1 and type 2 diabetes. Materials and methods. The object of the study is a depersonalized database of the Federal Registry of DM, implemented under the auspices of the Endocrinology Research Centre. The study was based on a retrospective analysis of patients with type 1 and type 2 diabetes with different GFR dynamics over a 5-year period of 20142018. 68 911 patients were included (type 1 DM 7919 and type 2 DM 60 992). Stepwise logistic regression analysis was used to predict the risk of developing CKD. Results. Sets of the most significant predictors of CKD development were established, which included 6 factors in type 1 DM: female sex, age, body mass index, the presence of myocardial infarction, diabetic coma and retinopathy, and 11 factors in type 2 DM: female sex, age, body mass index, glycated hemoglobin, baseline GFR and total cholesterol, presence of diabetic retinopathy, neuropathy, stroke, amputations and oncology in anamnesis. Conclusion. An applied interactive CKD prognosis calculator has been developed that allows assessing the individual risk of developing pathology in patients with type 1 and type 2 diabetes based on the parameters available in routine clinical practice. The calculator has been introduced into the system of the Federal Registry of DM, which significantly expands the possibilities of diagnosing and monitoring CKD in DM.

30 November 2022 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
IKI. V. Kononenko
I. V. Kononenko
MSMarina Shestakova
Marina Shestakova
AEA. R. Elfimova
A. R. Elfimova
IKI. A. Khomyakova
I. A. Khomyakova
ABA. P. Buzhilova
A. P. Buzhilova
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
BACKGROUND: Russia is one of the most multinational states in the world. Identification of ethnic groups with a higher risk of developing DM2, analysis of risk factors for the development of DM2 will allow developing personalized approaches to the prevention and treatment of DM2.AIMS: To reveal ethnic features of the prevalence of carbohydrate metabolism disorders and risk factors for the development of DM2 in the adult population of the Russian Federation.MATERIALS AND METHODS. A retrospective analysis of the database of the national epidemiological cross-sectional study NATION was carried out. Depending on the self-specified nationality, on the basis of anthropological characteristics, the following ethnic groups were identified: “Mongoloid population”, “Peoples of the Volga region”, “Peoples of the North Caucasus”, “Peoples of Transcaucasia”, “Russians”. The analysis consisted of several stages and included: analysis of the anthropometric features of the selected groups, taking into account the presence of carbohydrate metabolism disorders (MO); study of the prevalence of violations of the MA in the selected ethnic groups; analysis of ethnic characteristics of risk factors for the development of type 2 diabetes; analysis of the frequency of violations of the MA in various ethnic groups, taking into account the territory of residence. MR disorders were defined as the presence of DM and/or prediabetes. In accordance with the WHO criteria, HbA1c≥6.5% corresponded to the diagnosis of DM, HbA1c values in the range of 5.7%≤HbA1c<6.5% to the diagnosis of prediabetes.RESULTS: The highest frequency of violations of the MA was observed in the group «Peoples of the Volga region» (31.2%), the lowest in the «Peoples of the North Caucasus» (15.6%). BMI in the group “Peoples of the Volga region” was significantly lower than in the group “Peoples of the North Caucasus. Violations of MR were more often observed in the abdominal nature of obesity, obesity of the 1st stage, age over 45 years in the groups «Mongoloid population» and «Peoples of the Volga region» than in the peoples of the «Northern Caucasus» and «Transcaucasia». The frequency of occurrence of SR violations among representatives of the Volga Peoples group living in their historical territories was higher than among Russians living in the same regions: 32.5% and 24.3% (p<0.001 χ2 criterion), and also higher than in the Russian CFD: 32.5% and 27.4%, respectively, p=0.001 (χ2 test). The prevalence of violations of the MA among the peoples of the North Caucasus was less than among the Russians of the Central Federal District — 13.9% and 27.36%, respectively (p<0.001 χ2 criterion). The prevalence of MR violations among representatives of the “Peoples of the North Caucasus” group living in their historical territories (n=598) was less than among those living in other regions of the Russian Federation (n=164) (13.9% and 21.95%, p= 0.012 criterion χ2).CONCLUSION: In the present work, for the first time, we analyzed the prevalence of MR disorders in various ethnic groups of the population of the Russian Federation, identified certain ethnic characteristics of DM2 risk factors and their contribution to the development of the disease. The obtained results should be used for planning preventive programs in various regions of the Russian Federation.

21 March 2023 in Clinical and experimental thyroidology
Verified
Journal Article
Open access
PDF file
EKE. A. Kolpakova
E. A. Kolpakova
AEA. R. Elfimova
A. R. Elfimova
LNL. V. Nikankina
L. V. Nikankina
IDI. N. Dyakov
I. N. Dyakov
KBK. K. Bushkova
K. K. Bushkova
ETEkaterina Troshina
Ekaterina Troshina
In the midst of continuing coronavirus infection (COVID-19) there has been an increase in the incidence of various autoimmune pathologies. Particular attention to the potential relationship between coronavirus infection and autoimmune diseases is attracted by the positive therapeutic effect of the treatment of severe forms of COVID-19 with drugs used in the treatment of rheumatologically diseases.The results of the study should be the starting point for understanding the mechanisms of possible breakdown of immunological tolerance and the development of autoimmune thyroid diseases.AIM: To assess the risks of developing autoimmune thyroid disease after COVID-19, and to investigate the effect of therapy in the acute period on the possible development of autoimmune thyroid diseases.MATERIALS AND METHODS: This prospective comparative study included patients hospitalized at the National Medical Research Center for Endocrinology with a clinical and laboratory analysis of COVID-19 and bilateral polysegmental viral pneumonia (n=41). Patients with COVID-19 were divided into two subgroups: a subgroup of patients who received tocilizumab therapy in acute period (n=10), the second subgroup of patients who received symptomatic therapy during the acute period COVID-19 (n=31).To assess the functional status of the thyroid gland all patients underwent observation of the thyroid-stimulating hormone (TSH), free triiodothyronine (T3f), free thyroxine (T4f), antibodies to thyroperoxidase (Ab-TPO) and antibodies to the TSH receptor (Ab-recTSH).The concentrations of 27 signaling molecules in the blood serum were assessed by the technology of multiplex flow immunoassay using the Bio-Plex Pro Human Cytokine 27-plex Assay kit of cytokines and chemokines: interleukins-1b, -1ra, -2, 4-10, -12, -13, -15, -17 (IL-1b, IL-1ra, IL-2, IL - 4-10, IL-12, IL-13, IL-15, IL-17), Eotaxin, fibroblast growth factor (FGF), granulocyte- macrophage colony stimulating factor (GM-CSF), granulocyte colony stimulating factor (G -CSF), interferon-gamma (IFN-g), IFNγ-inducible protein 10 (IP-10), monocyte chemotactic protein-1 (MCP-1), also known as monocyte chemotactic and activating factor (MCAF), macrophage inflammatory protein -1 (MIP-1a and -1b), platelet growth factor BB (PDGF-bb), Regulated on Activation Normal T-cell Expressed and Secreted (RANTES), tumor necrosis factor-alpha (TNF-a), vascular endothelial growth factor (VEGF).All patients denied the presence of thyroid diseases, palpation of the thyroid gland revealed nodular formations in 5% of patients, and appropriate recommendations were given to patients.RESULTS: The overt hypothyroidism was detected in 2.4% of patients, subclinical - in 7.3% of patients in six months after the onset of coronavirus infection, and also found increased levels of the Ab-TPO in six months after recovery (p = 0.023 - Wilcoxon test). In the group of patients with increased Ab-TPO levels after COVID-19, statistically significantly high levels of IFN-g (p = 0.007), Eotaxin (p = 0.008) were obtained. An increased Ab-recTSH were revealed in the group of patients with severe COVID-19 who did not receive pathogenetic therapy with tocilizumab in the acute period (p = 0.046 - Mann-Whitney test).CONCLUSION: The results of our study and the scientific work of foreign colleagues demonstrate the potential risks of developing autoimmune thyroid diseases after a coronavirus infection. A close relationship was found between changes in the thyroid profile and hyperactivation of the immune system with hyperproduction of pro-inflammatory interleukins in COVID-19. This statement is confirmed by the revealed overt and subclinical hypothyroidism, as well as an increase in Ab- TPO levels in this group of patients after a coronavirus infection (p = 0.023 - Wilcoxon test) with a simultaneous persistent increased levels of some pro-inflammatory cytokines in dynamics, determined by autoimmune thyroiditis.The hypothesis of thyroid tissue damage by pro-inflammatory cytokines during COVID-19, as well as the hypothesis suggesting a protective effect on the development of autoimmune thyroid diseases by therapy with tocilizumab in the acute period were confirmed by increased levels of Ab-recTSH in patients with severe COVID-19 who did not receive tocilizumab in the acute period (p = 0.046 - Mann-Whitney test).

1 January 2022 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
AGAnna Gorbacheva
Anna Gorbacheva
EBE.E. Bibik
E.E. Bibik
EDE.A. Dobreva
E.A. Dobreva
AEA.R. Elfimova
A.R. Elfimova
APA.S. Pushkareva
A.S. Pushkareva
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
Первичный гиперпаратиреоз (ПГПТ) ассоциирован с большей частотой ряда метаболических и сердечно-сосудистых заболеваний. Оценка распространенности этих нарушений необходима для определения тактики ведения пациентов с ПГПТ. На сегодняшний день такие эпидемиологические данные в мире и в Российской Федерации лимитированы. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить распространенность и структуру сердечно-сосудистой патологии, нарушений углеводного, липидного и пуринового обмена у пациентов с ПГПТ. МАТЕРИАЛ И МЕТОДЫ Исследование проведено на базе ФГБУ «НМИЦ эндокринологии» Минздрава России в период с января 2017 по декабрь 2021 г. В исследование включены 585 пациентов, госпитализированных по поводу верифицированного ПГПТ. Пациенты распределены в 3 группы в соответствии с возрастом. В группу A (n=119) вошли пациенты от 18 до 49 лет, в группу B (n=297) — пациенты от 50 до 65 лет, в группу C (n=152) — пациенты от 66 лет и старше. Все пациенты обследованы и получили лечение согласно действующим стандартам оказания медицинской помощи и клиническим рекомендациям. РЕЗУЛЬТАТЫ Частота ожирения в исследуемых группах составляла от 17,9 до 36,8%. Повышение концентрации триглицеридов отмечено у 19,7—34,5% пациентов, липопротеинов низкой плотности — у 54,8—73,3%, гиперурикемия выявлена у 47,0—54,1%. Частота сахарного диабета статистически значимо возрастала с увеличением возраста пациентов — от 4,2% у пациентов группы A до 19,1% у пациентов группы C, как и частота артериальной гипертензии (от 29,7 до 94,0% соответственно). У пациентов группы C частота ишемической болезни сердца достигала 21,9%. ЗАКЛЮЧЕНИЕ В настоящем исследовании продемонстрирована высокая частота ряда сердечно-сосудистых заболеваний, а также патологии липидного, углеводного и пуринового обмена у пациентов с первичным гиперпаратиреозом. Однако для принятия клинических решений на основании этих данных необходимы дальнейшие исследования.